otelixizumab
Showing 1 - 4 of 4
Graves Ophthalmopathy Trial in Newcastle upon Tyne (Otelixizumab - low dose, Otelixizumab - medium low dose, Otelixizumab -
Terminated
- Graves Ophthalmopathy
- Otelixizumab - low dose
- +5 more
-
Newcastle upon Tyne, United KingdomGSK Investigational Site
Oct 8, 2020
Diabetes, Type 1 Trial in Belgium (Otelixizumab)
Completed
- Diabetes Mellitus, Type 1
- Otelixizumab
-
Brussels, Belgium
- +5 more
May 31, 2017
Diabetes, Type 1 Trial in Canada, United States (Otelixizumab)
Terminated
- Diabetes Mellitus, Type 1
- Otelixizumab
-
Birmingham, Alabama
- +16 more
Oct 11, 2017
Arthritis, Rheumatoid Trial in Russian Federation, Spain, United Kingdom (Otelixizumab, Matching )
Terminated
- Arthritis, Rheumatoid
- Otelixizumab
- Matching placebo
-
Moscow, Russian Federation
- +6 more
Jun 7, 2017